The BMJ reports the royal colleges’ discontent with the new National Institute for Health and Care Excellence guideline […]

The government has promised the largest ever investment in drug treatment and recovery as part of a far […]

Shkreli’s former company Vyera settles for $40M in antitrust case, but ‘pharma bro’ still faces his own trial […]

A new study from The Neuro and eight collaborating international epilepsy centers has developed a simple web-based application […]

Biomedical engineers at Duke University have demonstrated a method for increasing the depth at which optical coherence tomography […]

A year after Poland’s top court imposed restrictions on abortion rights, the government plans to set up a […]

According to clinical data, Roche’s new COVID-19 treatment Actemra/RoActemra lowered mortality risk in critically ill adult patients.

Results show support in favour of heterologous dosing which may help to advance vaccination programmes in poorer countries.

Alvotech, battling AbbVie over its Humira biosim, raises $450M and tees up Nasdaq debut fkansteiner Tue, 12/07/2021 – […]

Former pharma CEO plundered millions from his own company, DOJ says fkansteiner Tue, 12/07/2021 – 11:16